Please use this identifier to cite or link to this item: http://hdl.handle.net/2067/47779
Title: Lack of in vivo cross-protection of two different betanodavirus species RGNNV and SJNNV in European sea bass Dicentrachus labrax
Authors: Pascoli, Francesco
Guazzo, Andrea
Buratin, Alessandra
Toson, Marica
Buonocore, Francesco 
Scapigliati, Giuseppe 
Toffan, Anna
Journal: FISH AND SHELLFISH IMMUNOLOGY 
Issue Date: 2019
Abstract: 
Viral encephalopathy and retinopathy (VER) is a severe infective disease characterized by neuropathological changes in several fish species associated with high mortality. The etiological agent is a virus belonging to the Nodaviridae family, genus Betanodavirus. To date, four different betanodavirus species have been officially recognized by International Committee on Taxonomy of Viruses (ICTV), namely the red-spotted grouper- (RGNNV), the striped jack- (SJNNV), the barfin flounder- (BFNNV) and the tiger puffer nervous necrosis virus (TPNNV). Moreover, two reassortants RGNNV/SJNNV and SJNNV/RGNNV have been described. Betanodaviruses can be classified into three different serotypes (A, B and C) that are antigenically different, so none (between serotype A and C) or partial (between serotype B and C) cross-immunoreactivity has been detected in vitro. In this study we investigated the in vivo cross-protection of the two main betanodavirus species (RGNNV and SJNNV), which belong to distinct serotype, by immunizing intraperitoneally (IP) juvenile sea bass with formalin inactivated RGNNV and SJNNV vaccines, followed by a challenge with RGNNV. Fish IP vaccinated with inactivated RGNNV showed a high protection value (85%). Serological analyses highlighted a great specific anti-NNV immunoglobulin M (IgM) production against the homologous virus, while a good seroconversion with low neutralization property was highlighted against the heterologous virus. In fish IP vaccinated with inactivated SJNNV the protection recorded was equal to 25%, significantly lower respect to the one provided by RGNNV IP vaccine. ELISA test detected good IgM production against the homologous virus, and a lower, but still detectable IgM production against the heterologous one. By contrast, serum neutralization test highlighted a poorly detectable antibody production unable to neutralize either the homologous or the heterologous virus. These results confirm that the two serotypes are not cross-protective in vivo. According to these findings, the production of multivalent formulation, or at least the provision of different types of vaccines based on both fish and virus species requirement, should be recommended in order to broaden the range of protection.
URI: http://hdl.handle.net/2067/47779
ISSN: 1050-4648
DOI: 10.1016/j.fsi.2017.10.033
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Appears in Collections:A1. Articolo in rivista

Files in This Item:
File Description SizeFormat
225 Manuscript_cross_protection_noda _13092017_biblio_revision_ok.docxFish Shellfish Immunol 2019 Accepted version50.51 kBMicrosoft Word XMLView/Open
Show full item record

SCOPUSTM   
Citations 10

18
Last Week
0
Last month
0
checked on Feb 13, 2025

Page view(s)

103
Last Week
1
Last month
15
checked on Feb 15, 2025

Download(s)

54
checked on Feb 15, 2025

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons